Category Archives: Blog

New Recessive Disease Carrier Panel by EXOME

New Recessive Disease Carrier Panel by EXOME

The new Recessive Disease Carrier Panel by Exome, BIOARRAY ADVANCE EXOME, is the most comprehensive Bioarray’s panel as it is based on whole exome sequencing and analyzes more than 3,000 genes.

The entire Bioarray Advance line has now three different options, each of which is adjusted to the needs of the patient.

  • New Bioarray Advance EXOME (+3000 genes)
  • Bioarray Advance Expanded (420 genes)
  • Bioarray Advance High Frequency (20 genes)


All Bioarray Advance carrier panels ensure full compatibility with other platforms on the market, being the most extensive option in terms of number of genes.

The report is done in just 15 days and is now also more compact and educational for both patients and donors.

Matching Platform

It is a  web solution to perform genetic matching for patients and donors who have previously performed the Bioarray Advance™ Carrier Panel.

With this platform, our clients will be able to automatically know if two people are compatible or if they have a high risk of conceiving a child affected by a genetic disease, based on previous genetic studies carried out on each member of the couple. Knowing about a high-risk situation enables the necessary actions to be programmed to eliminate said risk.

Thanks to this platform, IVF clinics will be able to make matchings of their choice, with the aim of maximizing compatibility in the selection of donors, reducing the risk of transmission of genetic diseases.

Our platform currently offers three types of genetic matching:

– Complete Matching:
The complete panel of 2000 genes from the New Bioarray Advance™ Exome is analyzed. Ideal for patients or those clinics that prefer to have all the information.

– High Frequency Matching:
Only the genes of a reduced panel chosen by the center are studied. Ideal for patients or those clinics that prefer to study only the most prevalent genes.

– High Frequency Matching X-linked:
The genes of a reduced panel at the choice of the center are studied, as well as all the genes associated with X-linked diseases of the complete panel. Ideal for ovum donors.

Welcome to our booth A17 in ESHRE 2022

Bioarray will be present at the ESHRE 38th Annual Meeting

Join us in our booth A17

 

The 38th Annual Meeting of the “European Society of Human Reproduction and Embryology” (ESHRE) will be held in Milan from July 3 to 6.

ESHRE is an important international event where experts in reproductive medicine and science meet to participate in scientific sessions and above all to network with their colleagues.

We will be delighted to welcome you at our stand A17 and present our entire range of reproductive genetics tests such as:

  • niPGT-A: Non invasivePGT-A
  • MicroVE: Analysis of the microbiome in the vagina and endometrium
  • BioER: Determination of the implantation window by transcriptomics
  • Bioarray Advance Exome: The most comprehensive carrier panel. Study of more than 1500 genes for genetic matching.

If you want to book an appointment with our team, click the button and select the time that best suits you.

Book an appointment with the Bioarray Team

 

See you soon at ESHRE, remember stand A17!

Upcoming Bioarray’s Webinars

The most innovative genetic testing for IVF

Don’t miss our next FREE WEBINARS. We will discuss about our most innovative reproductive genetics tests.

Speaker: Luis A. Alcaraz, PhD – Bioarray’s Scientific Director

Non-invasive PGT-A

niPGT-A as an alternative to trophectoderm biopsy

👉 ‍When: June 15

🕑 Time: 2:00 PM Central European Time

🇬🇧 Language: English

⌚ Duration: 30 minutes

Register at the following link for the non-invasive PGT-A webinar: https://bit.ly/3NdTC4u

MicroVE and BioER

MicroVE: Analysis of the microbiome of the vagina and endometrium.

BioER: Determination of the implantation window through transcriptomics

👉 ‍When: June 22

🕑 Time: 2:00 PM Central European Time

🇬🇧 Language: English

👉 Duration: 30 minutes

Register at the following link for the MicroVE and BioER webinar: https://bit.ly/3M97eNm

Don’t miss them!!!

Próximos Webinars Bioarray

Los tests más innovadores de Bioarray para FIV 

No te pierdas nuestros próximos WEBINARS GRATUITOS donde hablaremos en detalle de nuestros tests más innovadores de genética reproductiva.

El Dr. Luis A. Alcaraz, Director Científico de Bioarray, impartirá los webinars siguientes:

PGT-A no invasivo

niPGT-A como alternativa a la biopsia de trofoectodermo

👉Cuándo: 15 junio

👉Hora: 18:30

👉Idioma: Español

👉Duración: 30 mn

👉Regístrate en el siguiente enlace al webinar PGT-A no invasivo: https://bit.ly/3t6X2OA

MicroVE y BioER

MicroVE análisis del microbioma de la vagina y endometrio

BioER: Determinación de la ventana de implantación mediante transcriptómica

👉Cuándo: 22 junio

👉Hora: 18:30

👉Idioma: Español

👉Duración: 30 mn

👉Regístrate en el siguiente enlace al webinar MicroVE y BioER: https://bit.ly/3zcK3yE

Bioarray’s new matching platform for IVF

The new matching platform is a web solution for carrying out genetic matching in IVF treatments. It is specially designed for patients and donors who have previously performed the Bioarray Advance™ Carrier Panel. It is very simple to use.

With this platform, our clients will be able to automatically know if two people are compatible or if they have a high risk of conceiving a child affected by a genetic disease, based on previous genetic studies carried out on each member of the couple. Knowing about a high-risk situation enables the necessary actions to be programmed to eliminate said risk.

Thanks to this platform, IVF clinics will be able to make matchings of their choice, with the aim of maximizing compatibility in the selection of donors, reducing the risk of transmission of genetic diseases.

Our platform currently offers three types of genetic matching:

– Complete Matching:
The complete panel of 1500 genes from the Bioarray Advance ™ Carrier Panel is analized. Ideal for patients or those clinics that prefer to have all the information.

– High Frequency Matching:
Only the genes of a reduced panel chosen by the center are studied. Ideal for patients or those clinics that prefer to study only the most prevalent genes.

– High Frequency Matching X-linked:
The genes of a reduced panel at the choice of the center are studied, as well as all the genes associated with X-linked diseases of the complete panel. Ideal for ovum donors.

Bioarray – Welcome at our booth in MEDLAB 2022

Bioarray will be present in the 21st edition MEDLAB MIDDLE EAST 2022

Dubai World Trade Centre

January 24-27

For the first time, Bioarray will participate in the 21st edition of Medlab Middle East Congress – the region’s only multi-disciplinary congress.

The 2022 edition Medlab Middle East exhibition, the MENA region’s leading exhibition for the laboratory industry, will be held from 24th to 27th January 2022, at the Dubai World Trade Centre and Bioarray will be present with a booth at the Spanish area.

The theme for the year is “Connect with innovation that’s changing the face of diagnostics”. A host of government entities, industry leaders and influencers in their respective sectors are expected to support the exhibition, which returns as a co-located event with Arab Health for the healthcare and laboratory industries.

Technology will take centre stage at the 2022 edition. A series of panel discussions and keynote presentations from leaders within the industry will highlight the latest advancements within the sector. Medlab Middle East will showcase the latest innovations from the laboratory industry via a range of product displays and talks.

Bioarray invites you to join us at our booth: We will be placed at the Spanish area, in the hall Z1, in the booth number C44.

We will be delighted to welcome you and present  all our range of genetic testing.
Learn more about Medlab: https://www.medlabme.com/en/home.html

Pan-Cancer Comprehensve Assay Plus – Webinar Replay 22/06

Below you can watch our Webinar Replay about the Pan-Cancer Comprehensve Assay Plus, presented by our speaker Dr. Noemí Rives, PhD.

 

 

Our Pan – Cancer Comprehensive Assay PLUS analyses over 500 genes and provides clinically relevant information regarding TMB, MSI, hotspot SNVs and indels, CNVs, gene fusions, and splice variants, using only one sample.

MicroVE Vaginal and Endometrial Microbiota and BioER Endometrial Receptivity- Webinar Replay 17/06

Below you can watch our Webinar Replay about the MicroVE and BioER tests, presented by our speaker Dr. Luis A. Alcaraz, PhD.

 

 

Our MicroVE tests analyse the vaginal and endometrial microbiome to ensure that the female reproductive system is in good health.
BioER detects the implantation window to schedule the optimal implantation date and increase the chances of pregnancy.

 

Upcoming Free Webinars

MicroVE and BioER tests – Thursday 17th of June at 13:00 CET

Our speaker Dr. Luis A. Alcaraz, PhD will tell us all about Micro VE and BioER tests:

MicroVE: Analyses the vaginal and endometrial microbiome to ensure that the female reproductive system is in good health.
BioER: Detects the implantation window in order to schedule the optimal implantation date and increase the chances of pregnancy.

Please register here: https://buff.ly/2TNrkaf

 

Pan Cancer Comprehensive Assay PLUS – Tuesday 22nd of June at 13:00 CET

Our speaker Dr. Noemí Rives, PhD will explain in detail the Pan – Cancer Comprehensive Assay PLUS which analyses over 500 genes and provides clinically relevant information regarding TMB, MSI, hotspot SNVs and indels, CNVs, gene fusions, and splice variants, using only one sample.

Please sign up here: https://buff.ly/2U1O7iF

We hope to see you there!